BOLD Q2 2018 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena

BOLDBoundless Bio, Inc.

$26M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$59M

Net Income

-$57M

EPS (Diluted)

$-1.29

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$28M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$366M

Total Liabilities

$25M

Stockholders' Equity

$341M

Cash & Equivalents

$214M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$59M	-$41M	-43.7%
Net Income	-$57M	-$41M	-39.4%